Peter DeVilbiss

Experienced turnaround CEO/ 2x Successful Exits / Biotech Angel - VC Investor / Executive Advisor / Veteran

๐Ÿ“ United States๐Ÿ”„ Updated October 2026๐Ÿ’ผ 1 investments๐Ÿ“… 3 years investing๐Ÿ—“ Last invested Jan 2023
VC๐ŸŒ United States
1
Total investments
0
Early stage
0
Mid stage
0
Late stage
3y
Years active

Portfolio

1 investments ยท sorted by recency
All investments
Early stage
Mid stage
Late stage
Member and Investor
2023
Mid Atlantic Bio Angels group (MABA), is an angel investor group focused on new and emerging life science companies.
Experience ยท 2 entries
All (2)
Investments (1)
2023
Member and Investor
2023
Mid Atlantic Bio Angels group (MABA), is an angel investor group focused on new and emerging life science companies.
2005
Sr. Director / Director, R&D Portfolio Management
Aug 2005
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world โ€“ and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ